Compare PEO & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEO | POM |
|---|---|---|
| Founded | 1929 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Other Specialty Stores |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.0M | 640.8M |
| IPO Year | N/A | 2025 |
| Metric | PEO | POM |
|---|---|---|
| Price | $21.56 | $4.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.4K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $46,931,528.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.37 |
| 52 Week Low | $19.22 | $3.35 |
| 52 Week High | $23.80 | $6.43 |
| Indicator | PEO | POM |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | N/A |
| Support Level | $21.01 | N/A |
| Resistance Level | $21.85 | N/A |
| Average True Range (ATR) | 0.33 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 45.31 | 0.00 |
Adams Natural Resources Fund Inc is a non-diversified U.S. equity fund that invests in liquid energy and other natural resources stocks. The Fund's investment objectives are preservation of capital, reasonable income, and opportunity for capital gain. A majority of its assets are invested in petroleum or natural resources industries or industries connected to them. It has broad flexibility to invest in stocks of varying capitalizations and predominantly invests in stocks found in the S&P 500 Energy and S&P 500 Materials sectors.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.